In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way
Feb. 1, 1996
In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way the FDA deals with approval of drugs and medical devices. Today, it takes an average of 12 years and $359 million to bring a new drug onto the market. Sen. Nancy Kassebaum, R-Kan., who heads the Senate Labor and Human Resources Committee, is backing legislation that will reform the role of the FDA in the testing and review of new drugs and medical devices. Rep.Thomas Bliley, R-VA, who heads the Ho
In other FDA-related developments, members of Congress are promising an overhead in 1996 of the way the FDA deals with approval of drugs and medical devices. Today, it takes an average of 12 years and $359 million to bring a new drug onto the market. Sen. Nancy Kassebaum, R-Kan., who heads the Senate Labor and Human Resources Committee, is backing legislation that will reform the role of the FDA in the testing and review of new drugs and medical devices. Rep.Thomas Bliley, R-VA, who heads the House Commerce Committee, also promised swift action, saying he`s concerned that American companies and jobs are being forced overseas "where the climate is more conducive to innovation.
Office managers are the heart of every practice, valued for their compassion, dedication, and exceptional skill. This year’s Spa Day giveaway highlighted their impact—from problem...
Just as no treatment plan is exactly the same, neither are any two patients’ financial situations. Financial barriers can stand in the way of a patient receiving the care they...
One practice, multiple locations. It sounds pretty simple, but we know it requires an intentional, multilayered strategy to be successful. Discover how implementing cloud-based...
Cost limitations can be a big barrier to patients’ acceptance of dental care treatments. Click to learn more about Patterson CarePay+, a single, comprehensive financing option...
